Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | PDE4A | P27815 | 2/20 | 0.47 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.47 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.47 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.47 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10759200 | 0.84 | MAPT (0.50) | TRPA1MAPTL3MBTL1ALDH1A1POLB | |
| SCHEMBL294390 | 0.83 | ALDH1A1 (0.58) | TRPA1MAPTL3MBTL1ALDH1A1RAB9A | |
| SCHEMBL1477520 | 0.81 | PDE4A (0.49) | ALDH1A1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL2717444 | 0.81 | ESR1 (0.54) | L3MBTL1ALDH1A1HPGDTDP1TRPM8 | |
| SCHEMBL805356 | 0.80 | MAPT (0.61) | MAPTL3MBTL1ALDH1A1POLBRAB9A | |
| SCHEMBL15011014 | 0.80 | TRPA1 (0.45) | TRPA1MAPTL3MBTL1ALDH1A1POLB | |
| SCHEMBL9698430 | 0.80 | ESR1 (0.54) | MAPTALDH1A1HPGDKDM4EESR1 | |
| SCHEMBL11061818 | 0.80 | TRPA1 (0.55) | TRPA1MAPTALDH1A1POLBATM | |
| SCHEMBL9698937 | 0.80 | ESR1 (0.54) | MAPTALDH1A1HPGDKDM4EESR1 | |
| SCHEMBL12431917 | 0.80 | ESR1 (0.54) | MAPTALDH1A1HPGDKDM4EESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026041801-A1 | PURIFIED OILS, FATS, EMULSIONS AND FERMENTED COMPOSITIONS | CULTIVATED BIOSCIENCES SA (CH) | 2026-02-26 | — | — | WO | claimed |
| US-20190085007-A1 | 4-methylcatechol Derivatives and Uses Thereof | Thanares GmbH (DE) | 2019-03-21 | — | — | US | claimed |
| US-9834739-B2 | Fragrance composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2017-12-05 | — | — | US | claimed |
| US-20160347782-A1 | 4-methylcatechol Derivatives and Uses Thereof | Thanares GmbH (DE) | 2016-12-01 | — | — | US | claimed |
| US-20160333291-A1 | FRAGRANCE COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-11-17 | — | — | US | claimed |
| WO-2013034119-A1 | 4-METHYLCATECHOL DERIVATIVES UND USE THEREOF | Thanares GmbH (DE) | 2013-03-14 | — | — | WO | claimed |
| US-4650604-A | VANILLA | NAARDEN INTERNATIONAL N. V. (NL) | 1987-03-17 | — | — | US | claimed |
| WO-2026041801-A1 | PURIFIED OILS, FATS, EMULSIONS AND FERMENTED COMPOSITIONS | CULTIVATED BIOSCIENCES SA (CH) | 2026-02-26 | — | — | WO | disclosed |
| US-20250243427-A1 | PRECURSORS OF PHENOLIC FRAGRANT COMPOUNDS | GIVAUDAN SA (CH) | 2025-07-31 | — | — | US | disclosed |
| EP-4493552-A2 | COMPOSITIONS AND METHODS RELATED TO THE SIMULTANEOUS MANUFACTURE AND PURIFICATION OF FLAVOR AND FRAGRANCE MOLECULES | Natural Extraction Systems, LLC (US) | 2025-01-22 | — | — | EP | disclosed |
| US-20240417359-A1 | PRECURSORS OF PHENOLIC FRAGRANT COMPOUNDS | GIVAUDAN SA (CH) | 2024-12-19 | — | — | US | disclosed |
| CN-115974662-B | Synthesis method of bio-based vanillin or ethyl vanillin | 兄弟科技股份有限公司 | 2024-09-03 | — | — | CN | disclosed |
| EP-4419497-A1 | PRECURSORS OF PHENOLIC FRAGRANT COMPOUNDS | Givaudan SA (CH) | 2024-08-28 | — | — | EP | disclosed |
| EP-1670760-A1 | ORGANIC COMPOUNDS | Speedel Experimenta AG (CH) | 2006-06-21 | — | — | EP | disclosed |
| WO-2005061457-A1 | ORGANIC COMPOUNDS | SPEEDEL EXPERIMENTA AG (CH) | 2005-07-07 | — | — | WO | disclosed |
| EP-0917528-A1 | NEW AMIDINO DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS | Astra Aktiebolag (SE) | 1999-05-26 | — | — | EP | disclosed |
| WO-1998001422-A1 | NEW AMIDINO DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS | ASTRA AKTIEBOLAG (SE) | 1998-01-15 | — | — | WO | disclosed |
| EP-0179532-B1 | PERFUME COMPOSITION AND PERFUMED PRODUCTS WHICH CONTAIN ONE OR MORE O-ALKOXYPHENOLS AS PERFUME COMPONENT | NAARDEN INTERNATIONAL N.V. (NL) | 1987-08-19 | — | — | EP | disclosed |
| US-4650604-A | VANILLA | NAARDEN INTERNATIONAL N. V. (NL) | 1987-03-17 | — | — | US | disclosed |
| EP-0179532-A1 | Perfume composition and perfumed products which contain one or more o-alkoxyphenols as perfume component | NAARDEN INTERNATIONAL N.V. (NL) | 1986-04-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190085007-A1 | 4-methylcatechol Derivatives and Uses Thereof | ST3GAL3, GALE, DPP4 | TRPA1 3958/4885MAPT 1067/4885L3MBTL1 3349/4885 |
| US-20250243427-A1 | PRECURSORS OF PHENOLIC FRAGRANT COMPOUNDS | FOS, HAAO, HPD | TRPA1 377/4885MAPT 1659/4885L3MBTL1 4583/4885 |
| US-20240417359-A1 | PRECURSORS OF PHENOLIC FRAGRANT COMPOUNDS | HAAO, FOS, HPD | TRPA1 447/4885MAPT 1624/4885L3MBTL1 4661/4885 |
| US-20160347782-A1 | 4-methylcatechol Derivatives and Uses Thereof | ST3GAL3, GALE, DPP4 | TRPA1 3958/4885MAPT 1067/4885L3MBTL1 3349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.